Pharma 3.0: Doing Digital Health Better
Digital health solutions have the potential to solve many healthcare problems. Yet despite initiatives to unlock the value of digital health for pharma over the last decade, we're yet to see success at scale.
At this critical point, it’s worth reflecting on what didn't work, how we can learn from past experiments, and how pharma can move from opportunistic to strategic digital initiatives with real impact.
In this report, experts from the HealthXL advisory team, pharma and digital health companies look at:
- Building a framework for better digital health solutions
- Understanding the fit for digital in pharma and moving away from ‘one size fits all’
- Choosing success metrics that resonate
- Rethinking internal resources and partnering for a successful ecosystem
- Tailoring business models to achieve long term objectives.
A special thanks to all our contributors:
- Tessy Huss, Head of Market Research, HealthXL
- Laura Ardill, Digital Health Insights Manager, HealthXL
- Sarah Ann Kikkers, Digital Health Consultant, HealthXL
- Jo Peddhinti, Director, Digital Health Advisory, HealthXL
- Francesca Wuttke, CEO and Founder, Nen
- John Cairns, Global Head of Digital, Oncology Franchise, Sanofi
- Kal Patel, CEO and Co-Founder, BrightInsight
- Rod Hughes, Executive Medical Science Director, AstraZeneca
- Suhas Krishna, VP, Head of Product Management Digital Health, Bristol Myers Squibb
- Anders Tveteraas, International Head of Patient Solutions and Services, Novartis
- Amir Zur, Executive Director, Head of R&D Digital Health Products, Takeda
- Alexander Klein, Group Leader Digital Health, Personalised Healthcare Center of Excellence, Roche Pharma
- Matthew Bonam, VP, Head of BioPharmaceuticals R&D Digital Patient Health and Innovation, AstraZeneca
- Sophie Park, Managing Director G4A Investments and Partnerships, Bayer
- Karthick Kannan, Global Digital Health, Teva Pharmaceuticals
- Ethan Wergelis-Isaacson, Director, Enterprise Strategy, McKesson
- Alexander Condoleon, VP, Head of Digital Healthcare U.S., Sanofi
